MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors
NCT07004647
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Peritoneal Tumor
Interventions
DRUG:
Fludarabine
Sponsor
Ruijin Hospital